Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Consulting agrmnt
Appointed director
|
|
Guardion Health Sciences, Inc. (GHSI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/14/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/31/2023 |
8-K
| Quarterly results |
| 06/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/30/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/16/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
8-K
| Quarterly results |
| 03/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/24/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/06/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ... |
| 01/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 12/02/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
8-K
| Quarterly results |
| 07/26/2022 |
8-K
| Quarterly results |
| 06/16/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
8-K
| Quarterly results |
| 02/23/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"GUARDION HEALTH SCIENCES, INC. [CLASS A][CLASS B] COMMON STOCK PURCHASE WARRANT Warrant Shares: _______ Initial Exercise Date: February [ ], 2022 THIS [CLASS A][CLASS B] COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on [______________ 1 but not thereafter, to subscribe for and purchase from Guardion Health Sciences, Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant shall initially be issued and maintained...",
"PRE-FUNDED COMMON STOCK PURCHASE WARRANT GUARDION HEALTH SCIENCES, inc. Warrant Shares: _______ Initial Exercise Date: February __, 2022 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from Guardion Health Sciences, Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . In addition to the terms ...",
"GUARDION HEALTH SCIENCES, INC. PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Warrant Shares: _________ Initial Exercise Date: February 23, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, Roth Capital Partners, LLC or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to 5:00 p.m. on February 18, 2027 but not thereafter, to subscribe for and purchase from Guardion Health Sciences, Inc., a Delaware corporation , up to 1,850,000 shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is issued to the Holder pursuant to that cert...",
"Annex A: Form of Warrant Certificate Request Notice WARRANT CERTIFICATE REQUEST NOTICE To: VStock Transfer, LLC, as Warrant Agent for Guardion Health Sciences, Inc. The undersigned Holder of Common Stock Purchase Warrants in the form of Global Warrants issued by the Company hereby elects to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below: 1. Name of Holder of Warrants in form of Global Warrants: _____________________________ 2. Name of Holder in Warrant Certificate : ________________________________ 3. Number of Warrants in name of Holder in form of Global Warrants: ___________________ 4. Number of Warrants for which Warrant Certificate shall be issued: __________________ 5. Number of Warrants in name of Holder in form of Global Warrants after is...",
"VIA ELECTRONIC MAIL",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of February 18, 2022, between Guardion Health Sciences, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each...",
"PLACEMENT AGENCY AGREEMENT Guardion Health Sciences, Inc. February 18, 2022 Roth Capital Partners, LLC 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 Maxim Group LLC 300 Park Avenue, 16 th Floor 10022",
"Director of Public Relations",
"Director of Public Relations",
"Director of Public Relations" |
|
| 02/14/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ...|
Docs:
|
"AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED BYLAWS OF GUARDION HEALTH SCIENCES, INC. a Delaware Corporation Pursuant to resolutions of the Board of Directors of Guardion Health Sciences, Inc., a Delaware corporation adopted at a meeting of the Board held on February 12, 2022 and in accordance with the authority provided to the directors pursuant to Article XIII of the Corporation’ s Second Amended and Restated Bylaws , Article II, Section 5 of the Bylaws is amended in its entirety as follows as of February 12, 2022 : “SECTION 5. Quorum. At any meeting of the stockholders, the holders of at least thirty-three and one-third of the total number of outstanding shares of stock of the Corporation entitled to vote at the meeting, present in person or represented by proxy, shall constitute a qu..." |
|
| 01/28/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 01/27/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/12/2022 |
8-K/A
| Investor presentation |
| 01/10/2022 |
8-K
| Investor presentation |
| 12/27/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/17/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Guardion Health Sciences Issues Letter to Shareholders HOUSTON – December 16, 2021 – Guardion Health Sciences, Inc. , a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, issued the following Letter to Shareholders: Dear Fellow Shareholders, I am delighted to be able to communicate directly with you and share all the developments that have occurred involving Guardion over the last year. During the course of the past year, we have been working non-stop toward re-creating your company into becoming a premier provider of clinically proven, trusted health and wellness products. I feel like it is safe to say that the Guardion that began 2021 is not the same Guardion finishing the year 2021, and that we are op..." |
|
| 12/09/2021 |
8-K
| Quarterly results |
| 12/08/2021 |
8-K
| Quarterly results |
| 10/25/2021 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
| 10/22/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/23/2021 |
8-K
| Quarterly results |
| 09/10/2021 |
8-K
| Quarterly results |
| 08/24/2021 |
8-K
| Quarterly results |
| 08/16/2021 |
8-K
| Quarterly results |
| 08/10/2021 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits|
Docs:
|
"Consent of KPMG LLP, the independent auditors of Activ Nutritional, LLC",
"The audited financial statements and related notes thereto of Activ Nutritional, LLC as of and for the years ended December 31, 2020 and 2019, including the related audit report of the independent auditors, KPMG LLP, and the unaudited interim condensed financial statements and related notes thereto for the three months ended March 31, 2021 and 2020",
"The unaudited pro forma condensed combined financial information of Guardion Health Sciences, Inc., giving effect to the acquisition of Activ Nutritional, LLC, which includes the unaudited pro forma condensed combined balance sheet and related notes as of March 31, 2021 and the unaudited pro forma condensed combined statements of operations and related notes thereto for the three months ended March 31, 2021 and the year ended December 31, 2020" |
|
|
|
|